BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15670308)

  • 1. Characteristics and management of uterine sarcoma patients treated at the Tom Baker Cancer Centre.
    Kelly KL; Craighead PS
    Int J Gynecol Cancer; 2005; 15(1):132-9. PubMed ID: 15670308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uterine sarcoma: clinicopathological characteristics, treatment and outcome in Iran.
    Ghaemmaghami F; Karimi-Zarchi M; Gilani MM; Mousavi A; Behtash N; Ghasemi M
    Asian Pac J Cancer Prev; 2008; 9(3):421-6. PubMed ID: 18990014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on treatment of uterine sarcoma.
    Nam JH; Park JY
    Curr Opin Obstet Gynecol; 2010 Feb; 22(1):36-42. PubMed ID: 19923988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine sarcoma-current management and experience from a regional cancer centre in North India.
    Biswas A; Patel F; Kumar P; Srinivasan R; Bera A; Sharma SC; Rajwanshi A
    Arch Gynecol Obstet; 2013 Oct; 288(4):873-82. PubMed ID: 23580012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High grade undifferentiated uterine sarcoma: surgery, treatment, and survival outcomes.
    Tanner EJ; Garg K; Leitao MM; Soslow RA; Hensley ML
    Gynecol Oncol; 2012 Oct; 127(1):27-31. PubMed ID: 22750260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of aggressive histologic variants of endometrial carcinoma at the Tom Baker Cancer Centre between 1984 and 1994.
    Craighead PS; Sait K; Stuart GC; Arthur K; Nation J; Duggan M; Guo D
    Gynecol Oncol; 2000 May; 77(2):248-53. PubMed ID: 10785473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases].
    Leung F; Terzibachian JJ; Aouar Z; Govyadovskiy A; Lassabe C
    Gynecol Obstet Fertil; 2008 Jun; 36(6):628-35. PubMed ID: 18538624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001.
    Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A
    Gynecol Oncol; 2008 Oct; 111(1):74-81. PubMed ID: 18657852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uterine sarcoma: 14 years experience in KCCC.
    Al Wakiel H; Ragheb AM; Varghese A; Juzeer A; Vashista S; Albasmy A
    Gulf J Oncolog; 2008 Jul; (4):45-51. PubMed ID: 20084775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Uterine sarcoma treated by surgery and postoperative radiation therapy. Patterns of relapse, prognostic factors and role of radiation therapy].
    Coquard R; Romestaing P; Ardiet JM; Mornex F; Sentenac I; Gérard JP
    Bull Cancer; 1997 Jun; 84(6):625-9. PubMed ID: 9295866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic determinants in patients with stage I uterine papillary serous carcinoma: a 15-year multi-institutional review.
    Growdon WB; Rauh-Hain JJ; Cordon A; Garrett L; Schorge JO; Goodman A; Boruta DM; Horowitz NS; del Carmen MG
    Int J Gynecol Cancer; 2012 Mar; 22(3):417-24. PubMed ID: 22237383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of primary site on outcomes in leiomyosarcoma: a review of clinicopathologic differences between uterine and extrauterine disease.
    Farid M; Ong WS; Tan MH; Foo LS; Lim YK; Chia WK; Soh LT; Poon D; Lee MJ; Ho ZC; Jeevan R; Chin F; Teo M; Quek R
    Am J Clin Oncol; 2013 Aug; 36(4):368-74. PubMed ID: 22772425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Uterine sarcoma in Tunisia: retrospective study about 14 cases].
    Bouzid N; Kanoun Belajouza S; Boussen H; Bouaouina N
    Gynecol Obstet Fertil; 2014 Dec; 42(12):838-43. PubMed ID: 25155830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uterine sarcomas: a clinicopathologic study.
    Chiara S; Foglia G; Odicino F; Graziani A; Conte PF; Ragni N; Fulcheri E; Pescetto G
    Oncology; 1988; 45(6):428-33. PubMed ID: 3186152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of patients with sarcoma of the uterus].
    Bokhman IaV; Urmancheeva AF
    Vopr Onkol; 1989; 35(10):1245-51. PubMed ID: 2596071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterine sarcoma: an analysis of 74 cases.
    Covens AL; Nisker JA; Chapman WB; Allen HH
    Am J Obstet Gynecol; 1987 Feb; 156(2):370-4. PubMed ID: 3030107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
    Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P
    Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of advanced stage uterine sarcomas: a bone of contention.
    Zagouri F; Linardou H; Dimopoulos AM; Papadimitriou CA
    Eur J Gynaecol Oncol; 2009; 30(5):483-92. PubMed ID: 19899397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome of patients with uterine sarcomas.
    Sharma DN; Rath GK; Kumar S; Kumar L; Bhatla N; Gandhi AK; Hariprasad R
    J Cancer Res Ther; 2011; 7(3):270-4. PubMed ID: 22044806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine sarcoma: prognostic factors and treatment evaluation.
    Naaman Y; Shveiky D; Ben-Shachar I; Shushan A; Mejia-Gomez J; Benshushan A
    Isr Med Assoc J; 2011 Feb; 13(2):76-9. PubMed ID: 21443030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.